Fingerprint
Dive into the research topics of 'Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia
Pablo Elías Morande, Mariela Sivina, Angimar Uriepero, Noé Seija, Catalina Berca, Pablo Fresia, Ana Inés Landoni, Javier M. Di Noia, Jan A. Burger, Pablo Oppezzo
Research output: Contribution to journal › Article › peer-review
13
Scopus
citations